Alzheimer's Disease Clinical Trials near Seattle, WA
15 studies for Alzheimer's Disease are recruiting at 16 sites within 50 miles of Seattle, Washington, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Alzheimer's Disease trials in the US or all trials near Seattle.
Recruiting now
Alzheimer's Disease studies enrolling near Seattle
- Dominantly Inherited Alzheimer Network (DIAN)
NCT00869817
- Observational
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Washington (Seattle, WA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Late Onset Alzheimer's Disease
NCT05010603
- Observational
- Ages 55 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Washington (Seattle, WA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
NCT05552157
- Phase 2/3
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Washington (Seattle, WA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
NCT06411561
- Interventional
- Ages 60 years and older
- Sex: All
Nearest site: University of Washington (Seattle, WA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895
- Phase 3
- Ages 18 to 75 years
- Sex: All
Nearest site: University of Washington Medical Center (Seattle, WA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
NCT06647498
- Phase 2/3
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Washington (Seattle, WA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
NCT06922188
- Observational
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
NCT07094516
- Phase 2
- Ages 50 to 85 years
- Sex: All
Nearest site: University of Washington Medical Center (Seattle, WA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
NCT07602582
- Phase 3
- Ages 55 years and older
- Sex: All
Nearest sites: Northwest Clinical Research Center (Bellevue, WA); Universal Research Group (Tacoma, WA)
- Distance to nearest recruiting site
- ~6 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
NCT06540833
- Phase 2
- Ages 55 years and older
- Sex: All
Nearest site: Northwest Clinical Research Center (Bellevue, WA)
- Distance to nearest recruiting site
- ~6 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787
- Phase 3
- Ages 55 to 90 years
- Sex: All
Nearest site: Northwest Clinical Research Center (Bellevue, WA)
- Distance to nearest recruiting site
- ~6 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
NCT06847321
- Phase 2
- Ages 55 to 80 years
- Sex: All
Nearest site: Northwest Clinical Research Center (Bellevue, WA)
- Distance to nearest recruiting site
- ~6 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
NCT06887192
- Phase 2
- Ages 55 to 90 years
- Sex: All
Nearest site: Clinical Site (Bellevue, WA)
- Distance to nearest recruiting site
- ~6 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
NCT07011745
- Phase 3
- Ages 55 to 90 years
- Sex: All
Nearest site: EvergreenHealth Medical Center (Kirkland, WA)
- Distance to nearest recruiting site
- ~8 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595
- Phase 2
- Ages 55 to 85 years
- Sex: All
Nearest site: EvergreenHealth (Kirkland, WA)
- Distance to nearest recruiting site
- ~8 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Alzheimer's Disease clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.